Dr. David Hull, MD
What this data tells you about Dr. Hull
Dr. David Hull is a cytopathology physician in Irving, TX, with 18 years in practice. Based on federal Medicare data, Dr. Hull performed 18,821 Medicare services across 14,631 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hull received a total of $71 from 3 pharmaceutical and/or device companies across 3 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cytopathology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hull is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Cell examination of specimen, selective cellular enhancement technique | 2,376 | $36 | $100 |
| Detection test by nucleic acid for human papillomavirus (hpv), high-risk types | 2,080 | $34 | $69 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 2,009 | $26 | $66 |
| Infectious disease DNA/RNA test | 1,643 | $34 | $66 |
| Blood draw (venipuncture) | 1,406 | $8 | $24 |
| Tissue pathology examination, moderate complexity | 1,160 | $47 | $121 |
| Yeast/candida DNA test | 1,128 | $34 | $67 |
| Cell examination of urine, manual | 902 | $451 | $1,215 |
| PSA test (prostate cancer screening) | 864 | $18 | $28 |
| Pap test, automated thin layer preparation; automated system and manual rescreening | 551 | $26 | $67 |
| Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method | 413 | $217 | $772 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 343 | $20 | $52 |
| Detection test for gardnerella vaginalis (bacteria), amplified probe technique | 338 | $34 | $70 |
| Testosterone (hormone) level, total | 260 | $25 | $65 |
| Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test | 257 | $34 | $69 |
| Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique | 248 | $34 | $66 |
| Special stained specimen slides to examine tissue, each multiplex procedure | 248 | $119 | $288 |
| Psa (prostate specific antigen) measurement, free | 234 | $18 | $28 |
| Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique | 205 | $34 | $63 |
| Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique | 205 | $34 | $63 |
| Tissue staining for diagnosis, initial | 177 | $72 | $202 |
| Pap test, manual screening | 162 | $20 | $61 |
| Measurement of total estradiol (hormone) | 160 | $27 | $70 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician | 148 | $23 | $58 |
| Measurement of dna of bacteria in vaginal fluid specimen | 120 | $254 | $448 |
| Special stained specimen slides to examine tissue including interpretation and report | 105 | $62 | $137 |
| Tissue staining for diagnosis, additional | 105 | $59 | $155 |
| Complete blood count (CBC), automated | 102 | $6 | $17 |
| Detection of mycoplasma genitalium by dna or rna probe | 98 | $34 | $64 |
| Red blood cell concentration measurement | 92 | $2 | $5 |
| Blood count, hemoglobin | 83 | $2 | $5 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 74 | $34 | $74 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 71 | $34 | $74 |
| Comprehensive metabolic blood panel | 61 | $10 | $26 |
| Pathology examination of tissue using a microscope, moderately high complexity | 61 | $187 | $460 |
| Detection test by nucleic acid for herpes simplex virus, amplified probe technique | 50 | $34 | $66 |
| Basic metabolic blood panel | 48 | $8 | $21 |
| Pathology examination of tissue using a microscope, limited examination | 48 | $12 | $34 |
| Pap test | 45 | $15 | $59 |
| Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with manual screening and rescreening by cytotechnologist under physician supervision | 40 | $27 | $54 |
| Special stained specimen slides to identify organisms including interpretation and report | 37 | $82 | $184 |
| Complete blood count (CBC) with differential | 32 | $8 | $20 |
| Urinalysis with microscopic exam | 18 | $3 | $10 |
| Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only | 14 | $40 | $87 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hull is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 18 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hull experienced with cell examination of specimen, selective cellular enhancement technique?
Does Dr. Hull receive payments from pharmaceutical companies?
How do Dr. Hull's costs compare to other cytopathology physicians in Irving?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology